885 related articles for article (PubMed ID: 18286613)
61. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
62. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
Scurr DS; Latif AB; Sergeant V; Robertson WG
Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
[TBL] [Abstract][Full Text] [Related]
63. Characterization of Inner Medullary Collecting Duct Plug Formation Among Idiopathic Calcium Oxalate Stone Formers.
Rivera M; Cockerill PA; Enders F; Mehta RA; Vaughan L; Vrtiska TJ; Herrera Hernandez LP; Holmes DR; Rule AD; Lieske JC; Krambeck AE
Urology; 2016 Aug; 94():47-52. PubMed ID: 27210573
[TBL] [Abstract][Full Text] [Related]
64. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
[TBL] [Abstract][Full Text] [Related]
65. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
[TBL] [Abstract][Full Text] [Related]
66. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.
Evan AP; Lingeman JE; Coe FL; Parks JH; Bledsoe SB; Shao Y; Sommer AJ; Paterson RF; Kuo RL; Grynpas M
J Clin Invest; 2003 Mar; 111(5):607-16. PubMed ID: 12618515
[TBL] [Abstract][Full Text] [Related]
67. Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.
Williams J; Holmes RP; Assimos DG; Mitchell T
Urology; 2016 Jul; 93():224.e1-6. PubMed ID: 26972146
[TBL] [Abstract][Full Text] [Related]
68. Recurrence of renal lithiasis.
Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
[TBL] [Abstract][Full Text] [Related]
69. Surface phase transition of hydrated calcium oxalate crystal in the presence of normal and stone-formers' urine.
Akbarieh M; Tawashi R
Scanning Microsc; 1990 Jun; 4(2):387-93; discussion 393-4. PubMed ID: 2402611
[TBL] [Abstract][Full Text] [Related]
70. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
Jaeger P; Portmann L; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
[TBL] [Abstract][Full Text] [Related]
71. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
[TBL] [Abstract][Full Text] [Related]
72. [Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis].
Gambaro G; Baggio B; Favaro S; Cicerello E; Marchini F; Borsatti A
Nephrologie; 1984; 5(4):171-2. PubMed ID: 6441892
[TBL] [Abstract][Full Text] [Related]
73. Three pathways for human kidney stone formation.
Coe FL; Evan AP; Worcester EM; Lingeman JE
Urol Res; 2010 Jun; 38(3):147-60. PubMed ID: 20411383
[TBL] [Abstract][Full Text] [Related]
74. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
75. Fine structure of calcium oxalate monohydrate renal calculi.
Söhnel O; Grases F
Nephron; 1993; 63(2):176-82. PubMed ID: 8450909
[TBL] [Abstract][Full Text] [Related]
76. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
Aggarwal KP; Tandon S; Singh SK; Tandon C
Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
[TBL] [Abstract][Full Text] [Related]
77. Developmental aspects of calcium oxalate tubular deposits and calculi induced in rat kidneys.
Rushton HG; Spector M; Rodgers AL; Hughson M; Magura CE
Invest Urol; 1981 Jul; 19(1):52-7. PubMed ID: 7251328
[TBL] [Abstract][Full Text] [Related]
78. Metabolic syndrome and urinary stone composition: what factors matter most?
Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
[TBL] [Abstract][Full Text] [Related]
79. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
Favus MJ; Coe FL
Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
[TBL] [Abstract][Full Text] [Related]
80. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
Parks JH; Coe FL; Evan AP; Worcester EM
BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
